Valuation Regencell Bioscience Holdings Limited
Stocks
RGC
KYG7487R1002
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 5.500 USD | -0.18% |
|
+3.97% | -73.81% |
Company Valuation: Regencell Bioscience Holdings Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 450.3 | 299.8 | 43.72 | 8,426 |
| Change | - | -33.42% | -85.42% | 19,171.44% |
| Enterprise Value (EV) 1 | 434.7 | 288.7 | 35.85 | 8,422 |
| Change | - | -33.58% | -87.58% | 23,393.1% |
| P/E | -59.5x | -51.1x | -10.2x | -2,351x |
| PBR | 26.4x | 24.9x | 5.32x | 1,734x |
| PEG | -0x | 2.3x | 0.4x | 140.9x |
| Capitalization / Revenue | - | - | - | - |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | -58.2x | -48.3x | -8.09x | -2,281x |
| EV / EBIT | -57.1x | -46x | -7.57x | -2,234x |
| EV / FCF | -162x | -127x | -19.1x | -5,587x |
| FCF Yield | -0.62% | -0.79% | -5.25% | -0.02% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.0153 | -0.0119 | -0.008699 | -0.007248 |
| Distribution rate | - | - | - | - |
| Net sales | - | - | - | - |
| EBITDA 1 | -7.468 | -5.981 | -4.431 | -3.692 |
| EBIT 1 | -7.618 | -6.274 | -4.737 | -3.77 |
| Net income 1 | -7.446 | -5.871 | -4.302 | -3.584 |
| Net Debt 1 | -15.65 | -11.1 | -7.875 | -4.353 |
| Reference price 2 | 0.911 | 0.606 | 0.088 | 17.040 |
| Nbr of stocks (in thousands) | 494,489 | 494,489 | 494,489 | 494,489 |
| Announcement Date | 10/31/22 | 10/27/23 | 10/25/24 | 10/31/25 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.73B | |
| 33.86x | 6.04x | 17.97x | 0.95% | 49.81B | |
| -21.01x | 245.16x | -22.36x | -.--% | 44.06B | |
| 33.64x | 3.26x | 14.08x | -.--% | 42.99B | |
| 47.1x | 5.45x | 29.8x | -.--% | 40.88B | |
| 28.69x | 8.67x | 21.92x | 0.4% | 33.11B | |
| 33.78x | 5.53x | 25.14x | -.--% | 16.58B | |
| 24.18x | 2.1x | 9.1x | 1.11% | 14.63B | |
| 77.11x | 4.06x | 15.74x | -.--% | 13.76B | |
| Average | 32.17x | 35.03x | 13.92x | 0.31% | 28.73B | |
| Weighted average by Cap. | 27.59x | 46.64x | 12.61x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- RGC Stock
- Valuation Regencell Bioscience Holdings Limited
Select your edition
All financial news and data tailored to specific country editions
